Latest Health News
Trump Administration Proposes $2 Billion WHO Alternative
The Trump administration is proposing to spend $2 billion annually to build a U.S.-run global disease surveillance system to replace functions previously accessed through the World Health Organization after withdrawing from the agency last year. This effort would reconstruct laboratories, data-sharing networks, and rapid-response systems at a significantly higher cost than the prior WHO access
.
FDA Leadership Prioritizes Safety Review of SSRIs and RSV Vaccines
Tracy Beth Høeg, the new director of the FDA's Center for Drug Evaluation and Research, announced plans to scrutinize antidepressants (SSRIs) and respiratory syncytial virus monoclonal shots for babies. This marks the fifth directorship change at the center in less than a year as the administration focuses on vaccine and drug safety concerns
.
FDA Reverses Course on Moderna Flu Vaccine Review
Facing growing public concern about the administration's vaccine actions, the FDA reversed its previous decision and announced it would review Moderna's new mRNA-based flu vaccine after all. The decision reflects the administration's effort to address vaccine skepticism ahead of midterm elections
.
At-Home Leqembi Injectable Transforms Alzheimer's Treatment Access
The FDA approval of an at-home injectable form of Leqembi represents a potentially game-changing advancement in Alzheimer's treatment, improving accessibility for patients with early-stage disease. This approval complements the existing Leqembi and Kisunla treatments, both of which have demonstrated ability to slow cognitive decline in early-stage Alzheimer's patients
.
Roche's Giredestrant Advances Against Treatment-Resistant Breast Cancer
The FDA accepted a New Drug Application for Roche's giredestrant combined with everolimus for ESR1-mutated, ER-positive advanced breast cancer, with phase III data showing a 62% reduction in disease progression or death risk in the ESR1-mutated population. This oral combination could become the first approved selective estrogen receptor degrader combination in the post-CDK4/6 inhibitor setting
.
Cancer Five-Year Survival Rate Reaches Historic 70% Milestone
The American Cancer Society's 2026 report documents that the five-year relative survival rate for all cancers has reached 70% for 2015–2021, up dramatically from 49% in the mid-1970s. Immunotherapy and targeted treatments have driven extraordinary survival gains for advanced metastatic cancers, with metastatic melanoma survival improving from 16% to 35% in just 25 years
.
Scientists Discover Method to Reduce Immune Checkpoint Inhibitor Side Effects
Researchers at Cincinnati Children's discovered that blocking TNF signaling through the TNFR2 gene can dramatically reduce the risk of cardiac complications from immune checkpoint inhibitor cancer treatments. The findings, published February 20, 2026, revealed that cardiac complications result from new production of autoreactive T cells rather than tumor-induced T cell exhaustion
.
NICE Expands Type 2 Diabetes Treatment Options with Heart-Kidney Protection Focus
New guidance from NICE recommends using SGLT-2 inhibitor medicines earlier in treatment pathways and introducing GLP-1 receptor agonists and tirzepatide for some patients with type 2 diabetes. Analysis projects these changes could prevent approximately 17,000 deaths over three years across the UK by reducing heart attacks, strokes, and kidney problems
.
Western University Researchers Engineer Diatoms for Biofuel Production
Researchers at Western University's Schulich Medicine & Dentistry developed an innovative gene-editing method to deliver DNA into diatoms, enabling production of biofuels, vitamins, and other products. The breakthrough reduced preparation time from weeks to days and increased successful colonies from dozens to over 20,000 per experiment using a simple enzyme treatment
.
Novel HPV Vaccine Redesign Strengthens Cancer-Fighting T Cell Response
Northwestern researchers demonstrated that repositioning HPV protein fragments on a DNA-based nanovaccine dramatically strengthens the immune response by training T cells more effectively to hunt down cancer cells. This innovation in vaccine arrangement shows promise for improving cancer immunotherapy approaches
.
Lab-Grown Spinal Cord Model Replicates Real Injury for Treatment Testing
Researchers successfully built a realistic human mini spinal cord in the laboratory and used it to simulate traumatic injury, reproducing key damage including inflammation and scar formation seen in actual spinal cord injuries. The model enables testing of new treatments for spinal cord damage
.
AI System Interprets Brain MRI Scans in Seconds for Emergency Detection
Researchers at the University of Michigan created an artificial intelligence system that can interpret brain MRI scans in just seconds while accurately identifying a wide range of neurological conditions and determining which cases require emergency intervention. This breakthrough accelerates diagnosis of critical brain conditions
.